RxDoctor Payments Data

Paul Kirchner

Podiatrist · New Lenox, ILNPI 1790899979

Payments from drug & device makers

What this record shows

This record is dominated by other: $140,943 of the $143,117 with a category attached, or 98.5%. Smith+Nephew accounts for 98.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $141,265 and has fallen 99.9% since, to $119 in 2025. Among podiatrist clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$143,117in general payments, 2019–2025

Across 79 payments — averaging $1811.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$142K
  • Stryker$833
  • Organogenesis Inc.$461
  • Kerecis Limited$197
  • Johnson & Johnson$38
  • Orthofix Medical, Inc.$35
  • plus $38 from 2 others

What the payments were for

  • Travel & lodging$3190%
  • Food & beverage$1,5671%
  • Gifts$2880%
  • Other$140,94398%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$143,117 in reported general payments places this provider in the 95th percentile of 409 podiatrist providers in Illinois.

See all podiatrist providers in Illinois

Medicare billing

Part B allowed, 2024
$155,605
Medicare patients
422
Services billed
1,872

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin Hcl15$98
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$66
Acetaminophen-CodeineAcetaminophen With Codeine17$60
Gabapentin15$27
Meloxicam12$27

Paid to pharmacies, not to this prescriber.

Other podiatrist in New Lenox

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →